Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Senior

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
BMJ Open|May 17, 2024
Effect of metformin use on graft and patient survival in kidney transplant recipients with type 2 diabetes: a systematic review protocolFarooq Shamshad, Somkanya Tungsanga, Peter Senior, et al.
Frontiers in Endocrinology|July 27, 2017
Glycemic and Metabolic Effects of Two Long Bouts of Moderate-Intensity Exercise in Men with Normal Glucose Tolerance or Type 2 DiabetesSaeed Reza Eshghi, Kevin Fletcher, Étienne Myette-Côté, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 6, 2026
From language matters to stigma-free communication in diabetes: Evolution, challenges, and next stepsElizabeth Holmes-Truscott, Emmanuel Ekpor, Eloise Litterbach, et al.
JMIR Diabetes|May 9, 2023
Technology-Supported Integrated Care Innovations to Support Diabetes and Mental Health Care: Scoping ReviewMegan Racey, Carly Whitmore, Paige Alliston, et al.
Neurology and Therapy|May 16, 2020
Quality of Life Improves with Alemtuzumab Over 6 Years in Relapsing-Remitting Multiple Sclerosis Patients with or without Autoimmune Thyroid Adverse Events: Post Hoc Analysis of the CARE-MS StudiesAntonio Bertolotto, Rafael Arroyo, Elisabeth G Celius, et al.
Diabetes|November 14, 2025
Baseline Insulin Secretion Determines Response to Abatacept in Stage 1 Type 1 DiabetesAlfonso Galderisi, Alice L J Carr, Peter Taylor, et al.
The Canadian Journal of Cardiology|August 12, 2022
2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in AdultsG B John Mancini, Eileen O'Meara, Shelley Zieroth, et al.
Diabetes Care|June 13, 2019
Preventing Early Renal Loss in Diabetes (PERL) Study: A Randomized Double-Blinded Trial of Allopurinol-Rationale, Design, and Baseline DataMaryam Afkarian, Sarit Polsky, Afshin Parsa, et al.
The New England Journal of Medicine|June 25, 2020
Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 DiabetesAlessandro Doria, Andrzej T Galecki, Cathie Spino, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
BMJ Open|May 17, 2024
Effect of metformin use on graft and patient survival in kidney transplant recipients with type 2 diabetes: a systematic review protocolFarooq Shamshad, Somkanya Tungsanga, Peter Senior, et al.
Frontiers in Endocrinology|July 27, 2017
Glycemic and Metabolic Effects of Two Long Bouts of Moderate-Intensity Exercise in Men with Normal Glucose Tolerance or Type 2 DiabetesSaeed Reza Eshghi, Kevin Fletcher, Étienne Myette-Côté, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 6, 2026
From language matters to stigma-free communication in diabetes: Evolution, challenges, and next stepsElizabeth Holmes-Truscott, Emmanuel Ekpor, Eloise Litterbach, et al.
JMIR Diabetes|May 9, 2023
Technology-Supported Integrated Care Innovations to Support Diabetes and Mental Health Care: Scoping ReviewMegan Racey, Carly Whitmore, Paige Alliston, et al.
Neurology and Therapy|May 16, 2020
Quality of Life Improves with Alemtuzumab Over 6 Years in Relapsing-Remitting Multiple Sclerosis Patients with or without Autoimmune Thyroid Adverse Events: Post Hoc Analysis of the CARE-MS StudiesAntonio Bertolotto, Rafael Arroyo, Elisabeth G Celius, et al.
Diabetes|November 14, 2025
Baseline Insulin Secretion Determines Response to Abatacept in Stage 1 Type 1 DiabetesAlfonso Galderisi, Alice L J Carr, Peter Taylor, et al.
The Canadian Journal of Cardiology|August 12, 2022
2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in AdultsG B John Mancini, Eileen O'Meara, Shelley Zieroth, et al.
Diabetes Care|June 13, 2019
Preventing Early Renal Loss in Diabetes (PERL) Study: A Randomized Double-Blinded Trial of Allopurinol-Rationale, Design, and Baseline DataMaryam Afkarian, Sarit Polsky, Afshin Parsa, et al.
The New England Journal of Medicine|June 25, 2020
Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 DiabetesAlessandro Doria, Andrzej T Galecki, Cathie Spino, et al.
Pageof 7